Metabolic Accelerator PM is a stimulant-free fat burner that increases your metabolic rate and activates brown fat cells, making it a great supplement to take if your goal is to lose weight.
Each serving of Metabolic Accelerator PM contains a clinical dosage of CaloriBurn GP™. Scientific literature has dubbed CaloriBurn PM as the “Holy Grail” of optimizing body composition and fat loss.
This formula wouldn’t be complete without a blend of natural herbs that will help calm your body and mind to help you get a restful sleep.
Getting rid of stubborn body fat is tough and it gets tougher as we age. Sometimes dieting, exercising and getting a good nights rest just isn’t enough to lose that stubborn fat that you’ve been carrying around for years. This is where the addition of a powerful, stimulant-free metabolic accelerator can make a HUGE difference.
There are three key reasons, which hold many people back from burning more body fat:
With Metabolic Accelerator PM you can successfully address these. First, Metabolic Accelerator PM helps increase calorie burning while you sleep. By supporting your resting metabolic rate, it helps create an environment that is more conducive to overnight fat-burning.
Next, Metabolic Accelerator PM promotes deeper sleep. Chances of you walking around the house at night with food and hunger cravings are diminished.
Furthermore, sleeping well helps keep cortisol levels lower. Cortisol is a stress hormone, that gets in the way of losing weight.
For best results, take two (2) capsules prior to bedtime or as suggested by a qualified healthcare professional.
WARNING: Use only as directed. Consult Your health care provider before use if you are pregnant or nursing, have a serious medical condition, or use prescription medications. For adult use only. Do not use in conjunction with alcoholic beverages, when driving a vehicle or while operating machinery. DO NOT USE IF SAFETY SEAL IS MISSING. Keep out of reach of children.
1 Attimarad, Mahesh et al; “High-performance thin layer chromatography: A powerful analytical technique in pharmaceutical drug discovery.”; Pharmaceutical methods; vol. 2,2; 2011; 71-5; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658041/
2 Sugita, Jun, et al; “Grains of Paradise (Aframomum Melegueta) Extract Activates Brown Adipose Tissue and Increases Whole-Body Energy Expenditure in Men.”; The British Journal of Nutrition; U.S. National Library of Medicine; Aug. 2013; https://pubmed.ncbi.nlm.nih.gov/23308394
3 Tackie AN, Dwuma-Badu D, Ayim JSK, Dabra TT, Knapp JE, Slatkin DJ, Schiff PL., Jr. “Constituents of West African medicinal plants. VIII. Hydroxyphenylalkanones from Amomum melegueta” Phytochemistry. 1975;14:853–854; https://agris.fao.org/agris-search/search.do?recordID=US201302734991
4 Al-Amin, Zainab M, et al; “Anti-Diabetic and Hypolipidaemic Properties of Ginger (Zingiber Officinale) in Streptozotocin-Induced Diabetic Rats.”; The British Journal of Nutrition; U.S. National Library of Medicine; Oct. 2006; https://pubmed.ncbi.nlm.nih.gov/17010224/
5 Jolad, Shivanand D, et al; “Commercially Processed Dry Ginger (Zingiber Officinale): Composition and Effects on LPS-Stimulated PGE2 Production.”; Phytochemistry; U.S. National Library of Medicine; July 2005; https://pubmed.ncbi.nlm.nih.gov/15996695
6 Wei, Chien-Kei et al; “6-Paradol and 6-Shogaol, the Pungent Compounds of Ginger, Promote Glucose Utilization in Adipocytes and Myotubes, and 6-Paradol Reduces Blood Glucose in High-Fat Diet-Fed Mice.”; International journal of molecular sciences; vol. 18,1; 168; 17 Jan. 2017; doi:10.3390/ijms18010168; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297801/
7 Gaire, Bhakta Prasad et al; “Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microglia.”; PloS one; vol. 10,3; e0120203; 19 Mar. 2015; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366308/
8 Ilic, Nebojsa et al.; “Toxicological evaluation of grains of paradise (Aframomum melegueta) [Roscoe] K. Schum.”; Journal of ethnopharmacology; vol. 127,2; 2010; 352-6; doi:10.1016/j.jep.2009.10.03; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815460/
9 Sidossis, L, et al; “Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed”; American Journal of Physiology; 270(4 Pt 1):E733-8; April 1996; https://pubmed.ncbi.nlm.nih.gov/8928782
10 Bonadonna, R; “Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans”; The American Journal of Physiology; 259(5 Pt 1):E736-50; November 1990; https://pubmed.ncbi.nlm.nih.gov/2240211
11 Rosell, Meritxell et al; “Brown and white adipose tissues: intrinsic differences in gene expression and response to cold exposure in mice.”; American journal of physiology. Endocrinology and metabolism; vol. 306,8; 2014; E945-64; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989735/
12 Saito, Masayuki; “Human Brown Adipose Tissue: Regulation and Anti-Obesity Potential.”; Endocrine Journal; U.S. National Library of Medicine; 2014; https://pubmed.ncbi.nlm.nih.gov/24401694
13 Iwami, Momoe, et al; “Extract of Grains of Paradise and Its Active Principle 6-Paradol Trigger Thermogenesis of Brown Adipose Tissue in Rats.”; Autonomic Neuroscience : Basic & Clinical; U.S. National Library of Medicine; 26 Apr. 2011; https://pubmed.ncbi.nlm.nih.gov/21185236
14 Sugita, Jun, et al; “Daily Ingestion of Grains of Paradise (Aframomum Melegueta) Extract Increases Whole-Body Energy Expenditure and Decreases Visceral Fat in Humans.”; Journal of Nutritional Science and Vitaminology; U.S. National Library of Medicine; 2014; https://www.jstage.jst.go.jp/article/jnsv/60/1/60_22/_pdf
15 Gaire, Bhakta Prasad et al; “Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microglia.”; PloS one; vol. 10,3; e0120203; 19 Mar. 2015; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366308/
16 Adefegha, Stephen A. et al; “Alligator pepper/Grain of Paradise (Aframomum melegueta) modulates Angiotensin-I converting enzyme activity, lipid profile and oxidative imbalances in a rat model of hypercholesterolemia”; Pathophysiology; Volume 23, Issue 3, 191 – 202; https://www.pathophysiologyjournal.com/article/S0928-4680(16)30026-8/fulltext